Whalegun
Home

Elliot Norry, Chief Medical Officer: Adaptimmune Therapeutics ADAPY Sell · Filed 23/01/17

Trade details

Type
Insider sale
Amount
$4,015.74
Shares · price
2,159 sh · $1.86 a share
Held after
3,491 sh
Stock
Adaptimmune Therapeutics ADAPY
Person
Elliot NorryChief Medical Officer
Trade date
23/01/17
Filed
23/01/17
Days to filing
0 days

Sold 38.2% of holdings

Share of holding sold
38.2%

Adaptimmune Therapeutics trades, last 26 weeks

What else happened in Adaptimmune Therapeutics around then

Filed or reported within 30 days of the trade day · 22/12/18~23/02/16

Elliot Norry's recent trades

  • Elliot Norry

    SellAdaptimmune Therapeutics

    $3,239

    Filed 25/01/17

  • Elliot Norry

    Planned saleAdaptimmune Therapeutics

    $3,243

    Filed 25/01/17

  • Elliot Norry

    SellAdaptimmune Therapeutics

    $5,588

    Filed 25/01/15

  • Elliot Norry

    SellAdaptimmune Therapeutics

    $4,793

    Filed 25/01/15

  • Elliot Norry

    SellAdaptimmune Therapeutics

    $2,518

    Filed 25/01/15

Elliot Norry, Chief Officer — sold $4,016 of Adaptimmune Therapeutics ADAPY · 38.2% of holdings | Whalegun